Newsroom

Sorted by: Latest

-

TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans

BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics is first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy....
-

Eastnets Double Award Win at 2025 MEA Finance Banking Technology Awards

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Eastnets, a global leader in compliance, payments, and cloud solutions, has been crowned winner of two awards at the 2025 MEA Finance Banking Technology Awards. Eastnets has been awarded ‘Most Innovative Payment Solutions Provider’ and ‘Best AML/KYC Solution’, acknowledging the company’s commitment to driving innovation in secure financial messaging, payment protection, and anti-money laundering solutions across the region. A leader in protecting th...
-

Ranpak Expands its Global Footprint Through Large-Scale Sustainable Packaging Partnership with Thalia

CONCORD TOWNSHIP, Ohio & HAGEN, Germany--(BUSINESS WIRE)--Ranpak, a leader in sustainable packaging and automation solutions, has partnered with Thalia, the largest book retail chain in the DACH region....
-

Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE...
-

TotalEnergies SE UK Regulatory Announcement: Transaction in Own Shares

PARIS--(BUSINESS WIRE)--  In accordance with the authorizations given by the shareholders’ general meeting on May 24, 2024, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from May 05 to May 09, 2025: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/share) Amount of tr...
-

Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the results of resolutions presented at its Combined General Meeting (CGM), held on May 12, 2025, and made them available on the dedicated section of its website. All resolutions recommended by the Board and submitted to the Combined Genera...
-

Poxel publie son chiffre d’affaires pour le premier trimestre 2025 et fait le point sur sa situation

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants pour les maladies chroniques graves à physiopathologie métabolique, dont la stéatohépatite associée à un dysfonctionnement métabolique (MASH) et les maladies métaboliques rares, publie aujourd'hui son chiffre d'affaires pour le premier trimestre clos le 31 mars 2025 et fait le point sur sa situation. Thomas Kuhn, Directeur...
-

Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today reported its revenue for the quarter ended March 31, 2025 and provided corporate update. Thomas Kuhn, Chief Executive Officer of Poxel, stated: “TWYMEEG® has further dem...
-

Sensorion publie les résultats des votes de l’Assemblée générale mixte des actionnaires

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui les résultats du vote des résolutions présentées lors de son Assemblée générale mixte (AGM), tenue le 12 mai 2025 et leur mise à disposition dans la section dédiée du site internet de la Société. Toutes les...
-

New Wellness Clinic, Pacific Northwest Massage and Body Restoration, Bringing Insurance-Based Massage and Cutting-Edge Recovery Therapies to Bellevue

BELLEVUE, Wash.--(BUSINESS WIRE)--Pacific Northwest Massage and Body Restoration, a new therapeutic wellness clinic offering massage therapy and state-of-the-art recovery modalities, will open its doors to the public on June 1, with a grand opening celebration on June 15. The clinic is changing the way the community experiences health and healing by combining clinical care with accessibility. What makes this practice stand out? It's one of the only stand-alone massage clinics in the region that...